Skip to main content

Peer Review reports

From: A clinical study of pegylated recombinant human granulocyte colony stimulating factor (PEG-rhG-CSF) in preventing neutropenia during concurrent chemoradiotherapy of cervical cancer

Original Submission
16 Dec 2020 Submitted Original manuscript
11 Feb 2021 Reviewed Reviewer Report
16 Feb 2021 Reviewed Reviewer Report
1 Mar 2021 Reviewed Reviewer Report
7 Mar 2021 Reviewed Reviewer Report - Ankita Srivastava
13 Mar 2021 Reviewed Reviewer Report - Surya Pandey
14 Mar 2021 Reviewed Reviewer Report
14 Apr 2021 Author responded Author comments - Dongling Zou
Resubmission - Version 2
14 Apr 2021 Submitted Manuscript version 2
30 Apr 2021 Reviewed Reviewer Report
1 May 2021 Reviewed Reviewer Report - Surya Pandey
3 May 2021 Reviewed Reviewer Report
9 May 2021 Reviewed Reviewer Report
9 May 2021 Reviewed Reviewer Report - Ankita Srivastava
9 May 2021 Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
17 May 2021 Editorially accepted
2 Jun 2021 Article published 10.1186/s12885-021-08364-9

You can find further information about peer review here.

Back to article page